AAAAAA

   
Results: 1-25 |
Results: 25
DNA fingerprinting of serial Candida albicans isolates obtained during itraconazole prophylaxis in patients with AIDS
Authors: Le Monte, AM Goldman, M Smedema, ML Connolly, PA McKinsey, DS Cloud, GA Kauffman, CA Wheat, LJ
Citation: Am. Le Monte et al., DNA fingerprinting of serial Candida albicans isolates obtained during itraconazole prophylaxis in patients with AIDS, MED MYCOL, 39(2), 2001, pp. 207-213
Emergence of resistance to fluconazole as a cause of failure during treatment of histoplasmosis in patients with acquired immunodeficiency disease syndrome
Authors: Wheat, LJ Connolly, P Smedema, M Brizendine, E Hafner, R
Citation: Lj. Wheat et al., Emergence of resistance to fluconazole as a cause of failure during treatment of histoplasmosis in patients with acquired immunodeficiency disease syndrome, CLIN INF D, 33(11), 2001, pp. 1910-1913
Multicenter case-control study of risk factors for histoplasmosis in humanimmunodeficiency virus-infected persons
Authors: Hajjeh, RA Pappas, PG Henderson, H Lancaster, D Bamberger, DM Skahan, KJ Phelan, MA Cloud, G Holloway, M Kauffman, CA Wheat, LJ
Citation: Ra. Hajjeh et al., Multicenter case-control study of risk factors for histoplasmosis in humanimmunodeficiency virus-infected persons, CLIN INF D, 32(8), 2001, pp. 1215-1220
Effects of treatment intensification with hydroxyurea in HIV-infected patients with virologic suppression
Authors: Havlir, DV Gilbert, PB Bennett, K Collier, AC Hirsch, MS Tebas, P Adams, EM Wheat, LJ Goodwin, D Schnittman, S Holohan, MK Richman, DD
Citation: Dv. Havlir et al., Effects of treatment intensification with hydroxyurea in HIV-infected patients with virologic suppression, AIDS, 15(11), 2001, pp. 1379-1388
Clearance of fungal burden during treatment of disseminated histoplasmosiswith liposomal amphotericin B versus itraconazole
Authors: Wheat, LJ Cloud, G Johnson, PC Connolly, P Goldman, M Le Monte, A Fuller, DE Davis, TE Hafner, R
Citation: Lj. Wheat et al., Clearance of fungal burden during treatment of disseminated histoplasmosiswith liposomal amphotericin B versus itraconazole, ANTIM AG CH, 45(8), 2001, pp. 2354-2357
Chronic infection and reactivation in a pulmonary challenge model of histoplasmosis
Authors: Durkin, M Kohler, S Schnizlein-Bick, C LeMonte, A Connolly, P Goldberg, J Garringer, T Wheat, LJ
Citation: M. Durkin et al., Chronic infection and reactivation in a pulmonary challenge model of histoplasmosis, J INFEC DIS, 183(12), 2001, pp. 1822-1824
New advances in antifungal treatment
Authors: Finquelievich, JL Odds, FC Queiroz-Telles, F Wheat, LJ
Citation: Jl. Finquelievich et al., New advances in antifungal treatment, MED MYCOL, 38, 2000, pp. 317-322
Paromomycin: No more effective than placebo for treatment of cryptosporidiosis in patients with advanced human immunodeficiency virus infection
Authors: Hewitt, RG Yiannoutsos, CT Higgs, ES Carey, JT Geiseler, PJ Soave, R Rosenberg, R Vazquez, GJ Wheat, LJ Fass, RJ Antoninievic, Z Walawander, AL Flanigan, TP Bender, JF
Citation: Rg. Hewitt et al., Paromomycin: No more effective than placebo for treatment of cryptosporidiosis in patients with advanced human immunodeficiency virus infection, CLIN INF D, 31(4), 2000, pp. 1084-1092
Factors associated with severe manifestations of histoplasmosis in AIDS
Authors: Wheat, LJ Chetchotisakd, P Williams, B Connolly, P Shutt, K Hajjeh, R
Citation: Lj. Wheat et al., Factors associated with severe manifestations of histoplasmosis in AIDS, CLIN INF D, 30(6), 2000, pp. 877-881
Memorial: Arthur C. White, MD, 1925-1999
Authors: Wheat, LJ
Citation: Lj. Wheat, Memorial: Arthur C. White, MD, 1925-1999, CLIN INF D, 30(1), 2000, pp. 3-3
Disseminated infection due to rapidly growing mycobacteria in immunocompetent hosts presenting with chronic lymphadenopathy: A previously unrecognized clinical entity
Authors: Chetchotisakd, P Mootsikapun, P Anunnatsiri, S Jirarattanapochai, K Choonhakarn, C Chaiprasert, A Ubol, PN Wheat, LJ Davis, TE
Citation: P. Chetchotisakd et al., Disseminated infection due to rapidly growing mycobacteria in immunocompetent hosts presenting with chronic lymphadenopathy: A previously unrecognized clinical entity, CLIN INF D, 30(1), 2000, pp. 29-34
Diagnosis of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected patients with polymerase chain reaction: A blinded comparison tostandard methods
Authors: Torres, J Goldman, M Wheat, LJ Tang, X Bartlett, MS Smith, JW Allen, SD Lee, CH
Citation: J. Torres et al., Diagnosis of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected patients with polymerase chain reaction: A blinded comparison tostandard methods, CLIN INF D, 30(1), 2000, pp. 141-145
1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus
Authors: Masur, H Kaplan, JE Holmes, KK Alston, BL Ampel, N Anderson, JR Baker, AC Barr, D Bartlett, JG Bennett, JE Benson, CA Bozzette, SA Chaisson, RE Crumpacker, CS Currier, JS Deyton, L Drew, WL Duncan, WR Eisinger, RW El-Sadr, W Feinberg, J Freedberg, KA Furrer, H Gnann, JW Goldberger, MJ Goldie, S Goosby, EP Gross, PA Hafner, R Havlir, D Hooton, TM Jabs, DA Jacobson, MA Janoff, E Kitahata, M Kovacs, JV Leport, C Levin, MJ Lopez, JC Marco, M Mayers, DL Melnick, DA Mofenson, LM Montaner, JSG Moore, R Neaton, J Nelson, C O'Neill, JF Palefsky, J Pau, A Phair, JP Piscitelli, S Polis, MA Quinn, TC Reiss, P Rimland, D Sears, CL Seeff, L Sepkowitz, KA Slama, TG Sloand, EM Spector, SA Thomas, DL Van Dyke, RB Watts, DH Wheat, LJ Whitcup, SM Williams, P Wright, TC Castro, KG DeCock, KM Dowell, SF Dworkin, MS Dykewicz, C Ellerbrock, T Hajjeh, R Holmberg, S Holtgrave, DR Jaffe, HW Jones, JL Juranek, DD Mast, E Navin, T Pellett, PE Reeves, WC Stewart, JA Villarino, ME
Citation: H. Masur et al., 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus, CLIN INF D, 30, 2000, pp. S29-S65
Amphotericin B oral suspension for fluconazole-refractory oral candidiasisin persons with HIV infection
Authors: Fichtenbaum, CJ Zackin, R Rajicic, N Powderly, WG Wheat, LJ Zingman, BS
Citation: Cj. Fichtenbaum et al., Amphotericin B oral suspension for fluconazole-refractory oral candidiasisin persons with HIV infection, AIDS, 14(7), 2000, pp. 845-852
Comparison of an established antibody sandwich method with an inhibition method of Histoplasma capsulatum antigen detection
Authors: Garringer, TO Wheat, LJ Brizendine, EJ
Citation: To. Garringer et al., Comparison of an established antibody sandwich method with an inhibition method of Histoplasma capsulatum antigen detection, J CLIN MICR, 38(8), 2000, pp. 2909-2913
Typing of Histoplasma capsulatum isolates based on nucleotide sequence variation in the internal transcribed spacer regions of rRNA genes
Authors: Jiang, BD Bartlett, MS Allen, SD Smith, JW Wheat, LJ Connolly, PA Lee, CH
Citation: Bd. Jiang et al., Typing of Histoplasma capsulatum isolates based on nucleotide sequence variation in the internal transcribed spacer regions of rRNA genes, J CLIN MICR, 38(1), 2000, pp. 241-245
Comparison of the echinocandin caspofungin with amphotericin B for treatment of histoplasmosis following pulmonary challenge in a murine model
Authors: Kohler, S Wheat, LJ Connolly, P Schnizlein-Bick, C Durkin, M Smedema, M Goldberg, J Brizendine, E
Citation: S. Kohler et al., Comparison of the echinocandin caspofungin with amphotericin B for treatment of histoplasmosis following pulmonary challenge in a murine model, ANTIM AG CH, 44(7), 2000, pp. 1850-1854
Does long-term itraconazole prophylaxis result in in vitro azole resistance in mucosal Candida albicans isolates from persons with advanced human immunodeficiency virus infection?
Authors: Goldman, M Cloud, GA Smedema, M LeMonte, A Connolly, P McKinsey, DS Kauffman, CA Moskovitz, B Wheat, LJ
Citation: M. Goldman et al., Does long-term itraconazole prophylaxis result in in vitro azole resistance in mucosal Candida albicans isolates from persons with advanced human immunodeficiency virus infection?, ANTIM AG CH, 44(6), 2000, pp. 1585-1587
Comparison of a new triazole, posaconazole, with itraconazole and amphotericin B for treatment of histoplasmosis following pulmonary challenge in immunocompromised mice
Authors: Connolly, P Wheat, LJ Schnizlein-Bick, C Durkin, M Kohler, S Smedema, M Goldberg, J Brizendine, E Loebenberg, D
Citation: P. Connolly et al., Comparison of a new triazole, posaconazole, with itraconazole and amphotericin B for treatment of histoplasmosis following pulmonary challenge in immunocompromised mice, ANTIM AG CH, 44(10), 2000, pp. 2604-2608
Transmission of Histoplasma capsulatum by organ transplantation
Authors: Limaye, AP Connolly, PA Sagar, M Fritsche, TR Cookson, BT Wheat, LJ Stamm, WE
Citation: Ap. Limaye et al., Transmission of Histoplasma capsulatum by organ transplantation, N ENG J MED, 343(16), 2000, pp. 1163-1166
Amphotericin B combined with itraconazole or fluconazole for treatment of histoplasmosis
Authors: LeMonte, AM Washum, KE Smedema, ML Schnizlein-Bick, C Kohler, SM Wheat, LJ
Citation: Am. Lemonte et al., Amphotericin B combined with itraconazole or fluconazole for treatment of histoplasmosis, J INFEC DIS, 182(2), 2000, pp. 545-550
Memorial: Arthur C. White, MD, 1925-1999
Authors: Wheat, LJ
Citation: Lj. Wheat, Memorial: Arthur C. White, MD, 1925-1999, J INFEC DIS, 181(1), 2000, pp. 1-1
Itraconazole prophylaxis for fungal infections in patients with advanced human immunodeficiency virus infection: Randomized, placebo-controlled, double-blind study
Authors: McKinsey, DS Wheat, LJ Cloud, GA Pierce, M Black, JR Bamberger, DM Goldman, M Thomas, CJ Gutsch, HM Moskovitz, B Dismukes, WE Kauffman, CA
Citation: Ds. Mckinsey et al., Itraconazole prophylaxis for fungal infections in patients with advanced human immunodeficiency virus infection: Randomized, placebo-controlled, double-blind study, CLIN INF D, 28(5), 1999, pp. 1049-1056
1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus
Authors: Masur, H Kaplan, JE Holmes, KK Alston, BL Ampel, N Anderson, JR Baker, AC Barr, D Bartlett, JG Bennett, JE Benson, CA Bozzette, SA Chaisson, RE Crumpacker, CS Currier, JS Deyton, L Drew, WL Duncan, WR Eisinger, RW El-Sadr, W Feinberg, J Freedberg, KA Furrer, H Gnann, JW Goldberger, MJ Goldie, S Goosby, EP Gross, PA Hafner, R Havlir, D Hooton, TM Jabs, DA Jacobson, MA Janoff, E Kitahata, M Kovacs, JV Leport, C Levin, MJ Lopez, JC Marco, M Mayers, DL Melnick, DA Mofenson, LM Montaner, JSG Moore, R Neaton, J Nelson, C O'Neill, JF Palefsky, J Pau, A Phair, JP Piscitelli, S Polis, MA Quinn, TC Reiss, P Rimland, D Sears, CL Seeff, L Sepkowitz, KA Slama, TG Sloand, EM Spector, SA Thomas, DL Van Dyke, RB Watts, DH Wheat, LJ Whitcup, SM Williams, P Wright, TC Castro, KG DeCock, KM Dowell, SF Dworkin, MS Dykewicz, C Ellerbrock, T Hajjeh, R Holmberg, S Holtgrave, DR Jaffe, HW Jones, JL Juranek, DD Mast, E Navin, T Pellett, PE Reeves, WC Stewart, JA Villarino, ME Kaplan, JE
Citation: H. Masur et al., 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus, ANN INT MED, 131(11), 1999, pp. 873-908
Comparison of intraocular to plasma HIV-1 viral burden in patients with cytomegalovirus retinitis
Authors: Ciulla, TA Schnizlein-Bick, CT Danis, RP Frank, MO Wheat, LJ
Citation: Ta. Ciulla et al., Comparison of intraocular to plasma HIV-1 viral burden in patients with cytomegalovirus retinitis, AM J OPHTH, 127(2), 1999, pp. 221-223
Risultati: 1-25 |